Active surveillance and watchful waiting are 2 prostate cancer treatments that people often confuse. Pathologist Oleksandr N. Kryvenko, MD, FCAP, explains exactly what they are and who may benefit from them.
In this podcast, Dr. Wright and Dr. Edelson discuss the new joint clinical practice guideline on the use of neoadjuvant chemotherapy for newly diagnosed, advanced ovarian cancer from the Society of Gynecologic Oncology (SGO) and the American Society of Clinical Oncology (ASCO).
In this month’s From the Editor’s Desk post, Dr. Schapira writes about the importance of slowing down to face the challenges of a cancer diagnosis.
Cancer affects many people as they grow older, so it’s important to have scientific research that focuses on older adults. Dr. Stuart Lichtman discusses why studies haven’t focused on older adults in the past and what is being done to change that.
At the 2016 ASCO Annual Meeting, Vice President Joe Biden talked about the Moonshot Initiative and what the future of cancer research offers.
Apostolia-Maria Tsimberidou, MD, PhD, discusses recent research presented at the 2016 American Association for Cancer Research (AACR) Annual Meeting.
Oncology professionals from around the world are in Chicago for the ASCO Annual Meeting. There, they will discuss the latest advances and newest thoughts in cancer research. Today’s highlights cover research that could potentially have the greatest impact to patient care for breast cancer, glioblastoma, neuroblastoma, and multiple myeloma.
Oncology professionals from around the world are in Chicago for the ASCO Annual Meeting. There, they will discuss the latest advances and newest thoughts in cancer research. These studies provide a glimpse into the exciting future of precision medicine.
Dr. Schapira puts the ASCO Annual Meeting in context for people with cancer and their families.
Biopsies are central to the diagnosis of many cancers. Pathologist Aziza Nassar, MD, sheds light on some things people should understand about biopsy.